Screener
Corcept Therapeutics CORT Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Corcept Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
FAQ
- What is Corcept Therapeutics's current ratio?
- Corcept Therapeutics (CORT) reported current ratio of 2.9× in Q2 2026.
- How has Corcept Therapeutics's current ratio changed year-over-year?
- Corcept Therapeutics's current ratio decreased by 6.7% year-over-year, from 3.1× to 2.9×.
- What is the long-term trend for Corcept Therapeutics's current ratio?
- Over 5 years (2020 to 2025), Corcept Therapeutics's current ratio has grown at a -21.9% compound annual growth rate (CAGR), from 10.1× to 2.9×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Corcept Therapeutics's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude